AI guided Drug Development

Accelerated development of novel antibiotics and combination therapies based on rational drug design & companion diagnostics.

AI guided Drug Development

Accelerated development of novel antibiotics and combination therapies based on rational drug design & companion diagnostics.

Pharma Services

To accelerate discovery and development of novel antibiotics, we offer a comprehensive portfolio of data-driven services for antimicrobial drug discovery, clinical development, and product lifecycle management.

At Ares Genetics, we provide pharma services leveraging the entire Curetis Group solutions portfolio. Our services support data-driven target and lead prioritization, accelerate clinical trials, augment clinical data for regulatory submissions, as well as inform antimicrobial use for effective antibiotic stewardship post launch.

Accelerated Development

Rational drug design & lead prioritization.

Reduced Costs

Streamlined trials and fast-tracked drug development.

Increased Revenues

Improved product lifecycle management and optimal drug positioning.

Early Stage Development

Target and MoA Analysis

Customized in silico target characterization, epidemiology, and Mode of Action (MoA) analysis.

Lead Prioritization

In vitro high throughput resistance resting combined with customized in silico data analysis solutions to predict likelihood and mechanisms of resistance.

MDx Development

Advanced in silico tools combined with profound experience in molecular microbiology assay design for clinical trial and companion diagnostic use.

Biomarker Discovery

Identification, validation and epidemiological assessment of antibiotic drug specific biomarkers for clinical trials and companion diagnostics.

Clinical Development

Deep Pathogen Characterization

Deep profiling of pathogens using whole genome sequencing to enrich clinical trial data for regulatory submissions.

Optimized Enrolment

Customized and off-the-shelf multiplex PCR panels for pathogens and resistance markers enabling rapid, and targeted clinical trial enrolment.

Life Cycle Management

Companion Diagnostics

Customized multiplex PCR panels for rapid diagnostics and informed treatment decisions.

Molecular Epidemiology

Post-market surveillance, resistance evolution monitoring and services.